David Young - 10 Oct 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Pres. Research & Development, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
10 Oct 2023
Net transactions value
+$34,080
Form type
4
Filing time
10 Oct 2023, 17:03:32 UTC
Previous filing
12 Jun 2023
Next filing
12 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $34,080 +142,000 +30% $0.2400 612,424 10 Oct 2023 Direct
holding PCSA Common Stock 619,677 10 Oct 2023 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 215,703 10 Oct 2023 By Family Entities
holding PCSA Common Stock 370,887 10 Oct 2023 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.